Accessibility Statement Skip Navigation
  • Resources
  • Data Privacy
  • Contact Us
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Partnerships
    • Media Inquiries
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • All Multimedia

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Accessories
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High-Tech Security
      • Internet Technology
      • Nanotechnology
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Projections or Forecasts
      • Financing Agreements
      • Insurance
      • Investment Options
      • Joint Ventures
      • Mutual Funds
      • Offerings
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing/marketing agreements
      • New Products & Services
      • Obituary
      • Outsourcing Businesses
      • Overseas Real Estate (Non-US)
      • Personnel Announcements
      • Residential Real Estate
      • Small-Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Accessories
      • Computer Electronics
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Design Automation
      • Financial Technology
      • Mobile Devices/Apps
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Natural Gas Utilities
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Computer Accessories
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Computer Accessories
      • Computer Networks
      • Mobile Devices/Apps
      • Telecommunications
      • Telecommunications Carriers & Services
      • Telecommunications Equipment
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wine & Spirits
      • Beverages
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infectious Disease Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental Products & Services
      • European Government
      • Natural Disasters
      • Not-for-Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Children-related news
      • Disabled Persons
      • Diversity, Equity & Inclusion
      • Hispanic-oriented news
      • LGBTQ+
      • Religion
      • Senior Citizens
      • Veterans
      • Women-Related news
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring Home
  • Send a Release
    • Chat

    • ALL CONTACT INFO
    • Contact Us


  • News Releases
  • Send a Release
  • Data Privacy
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • News Releases
  • Send a Release
  • Data Privacy
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • News Releases
  • Send a Release
  • Data Privacy
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • News Releases
  • Send a Release
  • Data Privacy

New Peer-Reviewed Study Confirms Innovative Technology Shatters ESR's Four-Hour Deadline

  • USA - English
  • Korea - 한국어
  • USA - English
  • MEXICO - Spanish
  • Vietnam - Vietnamese
  • APAC - Traditional Chinese
ALCOR Scientific logo

News provided by

Alcor Scientific

17 Sep, 2026, 21:00 CST

Share this article

Share toX
SHARE A PRE-MADE POST

Share this article

Share toX
SHARE A PRE-MADE POST

ALCOR Scientific's iSED® analyzers reshape lab logistics and improve patient care for one of medicine's most widely used tests

  • Seven times longer stability, independently validated. ESR samples on ALCOR Scientific's iSED analyzer remained accurate for up to 28 hours at room temperature and 48 hours refrigerated, outperforming the four-hour limit of traditional Westergren testing.
  • A breakthrough for modern lab logistics. The extended sample stability delivers workflow and cost savings for clinical labs navigating scattered blood collection sites, longer courier routes and staffing shortages.
  • Improved patient care. With more than a full day of room-temperature stability, delayed and after-hours samples can be tested with confidence, reducing rejections and blood redraws while improving results and the patient experience.

SMITHFIELD, R.I., Sept. 17, 2026 /PRNewswire/ -- For a hundred years, one number has quietly governed erythrocyte sedimentation rate (ESR), a test doctors rely on to diagnose and monitor infections, autoimmune conditions and other diseases: four. As in four hours, the narrow window in which a traditional ESR sample had to be tested or refrigerated before its result could no longer be trusted. A new peer-reviewed study published in Diagnostics says that deadline belongs to the past.

Continue Reading
Diagnostics study
Diagnostics study

The study found that ESR samples measured by photometric rheology on ALCOR Scientific's iSED® analyzers remained accurate for up to 28 hours at room temperature and 48 hours refrigerated, seven times longer than the traditional Westergren method's four-hour room-temperature limit.

The impact is significant. One of the most widely used tests in medicine is no longer bound by a four-hour deadline. As clinical labs contend with scattered blood collection sites, longer courier routes and staffing shortages, the extended sample stability delivers immediate benefits to labs and the patients they serve.

The full study "Measuring Erythrocyte Sedimentation Rate Using Photometric Rheology Technology Demonstrates Superior Sample Stability as Compared to the Westergren Method," is available at https://www.mdpi.com/2075-4418/16/16/2648.

The problem hiding in the back of a courier van

ESR is one of the oldest tests in medicine, and one of the most widely ordered, with millions performed every year. It's a fast and affordable marker of inflammation that helps detect and monitor a range of conditions, from infections and autoimmune diseases like rheumatoid arthritis to inflammatory conditions like giant cell arteritis, as well as certain cancers. Unlike tests that measure a specific molecule, ESR measures a behavior: how quickly red blood cells aggregate and settle in a tube, which makes it acutely vulnerable to time and temperature.

That vulnerability collides head-on with how modern labs operate. At the same time, labs are consolidating into centralized, high-volume centers, they're navigating growing blood collection sites and staffing shortages. Between the needle and the analyzer sits a courier network that batches specimens onto multi-stop routes, often carrying them for hours in vehicles with no meaningful temperature control. Meeting a strict four-hour clock across that chain is often impossible. Worse, the failure is invisible because a degraded sample doesn't arrive flagged. It arrives looking perfectly normal, and its result gets reported and acted on like any other.

Beyond gravity: a new way to measure inflammation

The iSED analyzer takes a fundamentally different approach to ESR testing. Using photometric rheology technology, it optically captures red blood cell aggregation, the earliest and most critical step of erythrocyte sedimentation, inside a temperature-controlled flow cell, generating a result in less than 20 seconds. Because it reads the very beginning of the aggregation process in a controlled environment, the iSED analyzer is largely insulated from the time-sensitive changes that undermine traditional readings, extending sample stability seven times longer than traditional testing.

From four hours to 28: a breakthrough for labs

Extending sample stability from four hours to 28 in ESR is a breakthrough for laboratory logistics, offering labs and the patients they serve immediate, tangible benefits, including:

  • Reliable results: greater confidence in every result, especially when samples travel long distances or are delayed.
  • Fewer rejected samples: specimens delayed in transit or received during minimal-staffing hours can still be tested with confidence.
  • Fewer needle sticks for patients: sparing patients the burden of repeat phlebotomy for a common blood test.
  • One tube, two tests: with longer stability, the same EDTA tube can realistically serve both ESR and CBC testing, and add-on ESR requests become feasible.
  • Workflow and cost savings: a meaningful advantage as clinical laboratories navigate deepening workforce shortages.

"For decades, labs have been forced to build their entire ESR workflow around limited sample stability. Extending room temperature stability by an additional 24 hours is a game changer, not only improving logistics but truly improving patient care by ensuring reliable results. Giving labs a full day of reliable stability isn't a convenience. It's better medicine," said Jim Post, CEO, Alcor Scientific.

About the study

The study, "Measuring Erythrocyte Sedimentation Rate Using Photometric Rheology Technology Demonstrates Superior Sample Stability as Compared to the Westergren Method," was published in Diagnostics (2026;16(16):2648) by Koshy, Lamazares, Evans, and Jortani. The research was conducted under Institutional Review Board (IRB) approval at two hospital sites and funded by ALCOR Scientific.

About ALCOR Scientific
ALCOR Scientific develops diagnostic technologies that optimize laboratory efficiency. Founded in 2011, the company leverages its deep understanding of bioscience and state-of-the-art manufacturing techniques to design transformational solutions that help health care providers save time and improve patient care. ALCOR Scientific is one of the only providers to offer a fully automated solution for Erythrocyte Sedimentation Rate (ESR) testing for all laboratory throughputs and workflows. For more information, visit alcorscientific.com.

Media Contact
Megan McCutcheon, ALCOR Scientific
Email: [email protected]

SOURCE Alcor Scientific

Modal title

Also from this source

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable

The $9.95 Million Question: Is ESR Worth Keeping? A new ALCOR Scientific sponsored peer-reviewed study published in ClinicoEconomics and Outcomes...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Biotechnology

Biotechnology

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Careers
  • Accessibility Statement
  • APAC – Simplified Chinese
  • APAC
  • APAC - Traditional Chinese
  • Arabic
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
  • Vietnam

My Services

  • All New Releases
  • Platform

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
[email protected]
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
  • Accessibility
Copyright © 2026 Cision US Inc.